Code | 35575 | ||||||||||
MA number | EU/1/06/334/002 | ||||||||||
Product Form: | con inf 4x20 ml/20 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Sanofi B.V., Netherland | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass container | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application |
MA issued: | 29.05.2006 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 06.12.2021 |